Weiyi Mai

3.7k total citations · 1 hit paper
53 papers, 2.4k citations indexed

About

Weiyi Mai is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Weiyi Mai has authored 53 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 18 papers in Surgery and 11 papers in Molecular Biology. Recurrent topics in Weiyi Mai's work include Blood Pressure and Hypertension Studies (14 papers), Lipoproteins and Cardiovascular Health (13 papers) and Cardiovascular Health and Disease Prevention (7 papers). Weiyi Mai is often cited by papers focused on Blood Pressure and Hypertension Studies (14 papers), Lipoproteins and Cardiovascular Health (13 papers) and Cardiovascular Health and Disease Prevention (7 papers). Weiyi Mai collaborates with scholars based in China, United States and Australia. Weiyi Mai's co-authors include Xiaoyan Cai, Meijun Li, Dingli Xu, Sheng Wang, Hongfeng Tang, Yuli Huang, Anping Cai, Ruofeng Qiu, Yugang Dong and Yanxian Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Weiyi Mai

53 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis

2016 686 citations Xiaoyan Cai, Weiyi Mai et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weiyi Mai China	24	962	724	586	419	310	53	2.4k
W Grzeszczak Poland	31	637 0.7×	969 1.3×	587 1.0×	429 1.0×	217 0.7×	298	3.2k
Joop D. Lefrandt Netherlands	30	711 0.7×	765 1.1×	596 1.0×	476 1.1×	235 0.8×	87	2.8k
Carlos Posadas‐Romero Mexico	25	498 0.5×	648 0.9×	326 0.6×	412 1.0×	401 1.3×	129	2.2k
Toshifumi Mannami Japan	28	859 0.9×	671 0.9×	403 0.7×	415 1.0×	394 1.3×	46	2.2k
Ester Vitacolonna Italy	28	487 0.5×	777 1.1×	474 0.8×	604 1.4×	373 1.2×	78	3.0k
Rui‐Xing Yin China	28	787 0.8×	805 1.1×	791 1.3×	1.0k 2.4×	421 1.4×	162	3.0k
Susanna Morano Italy	35	533 0.6×	1.1k 1.5×	681 1.2×	490 1.2×	320 1.0×	132	3.6k
R.J. Heine Netherlands	27	516 0.5×	845 1.2×	539 0.9×	516 1.2×	299 1.0×	43	2.8k
Kupper A. Wintergerst United States	24	478 0.5×	707 1.0×	959 1.6×	428 1.0×	244 0.8×	65	2.5k
Ivonne Hernandez Schulman United States	30	732 0.8×	521 0.7×	645 1.1×	521 1.2×	160 0.5×	75	2.3k

Countries citing papers authored by Weiyi Mai

Since Specialization

Citations

This map shows the geographic impact of Weiyi Mai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyi Mai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyi Mai more than expected).

Fields of papers citing papers by Weiyi Mai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiyi Mai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyi Mai. The network helps show where Weiyi Mai may publish in the future.

Co-authorship network of co-authors of Weiyi Mai

This figure shows the co-authorship network connecting the top 25 collaborators of Weiyi Mai. A scholar is included among the top collaborators of Weiyi Mai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiyi Mai. Weiyi Mai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Luo, Ling, Junzhao Ye, Shuyu Zhuo, et al.. (2024). Specific metabolic impairments indicate loss of sustained liver improvements in metabolic dysfunction-associated steatotic liver disease treatment. HepatoBiliary Surgery and Nutrition. 13(4). 632–649. 2 indexed citations

Ye, Junzhao, Xiaorong Gong, Xin Li, et al.. (2021). Apolipoproteins and liver parameters optimize cardiovascular disease risk-stratification in nonalcoholic fatty liver disease. Digestive and Liver Disease. 53(12). 1610–1619. 6 indexed citations

Zhu, Hailan, Haoxiao Zheng, Xinyue Liu, Weiyi Mai, & Yuli Huang. (2020). Clinical applications for out-of-office blood pressure monitoring. Therapeutic Advances in Chronic Disease. 11. 1754193436–1754193436. 15 indexed citations

Wu, Jiandi, Haoxiao Zheng, Xinyue Liu, et al.. (2020). Prognostic Value of Secreted Frizzled-Related Protein 5 in Heart Failure Patients With and Without Type 2 Diabetes Mellitus. Circulation Heart Failure. 13(9). e007054–e007054. 44 indexed citations

Liu, Xinyue, Haoxiao Zheng, Xiaohui Huang, et al.. (2020). IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway. Stem Cell Research & Therapy. 11(1). 22–22. 78 indexed citations

Liu, Xinyue, Haoxiao Zheng, Hailan Zhu, et al.. (2020). Multiple Roles of sFRP2 in Cardiac Development and Cardiovascular Disease. International Journal of Biological Sciences. 16(5). 730–738. 35 indexed citations

Cai, Anping, et al.. (2020). Meta-Analysis Evaluating the Efficacy and Safety of Low-Intensity Warfarin for Patients >65 Years of Age With Non-Valvular Atrial Fibrillation. The American Journal of Cardiology. 142. 74–82. 6 indexed citations

Huang, Yuli, Weijun Huang, Weiyi Mai, et al.. (2017). White-coat hypertension is a risk factor for cardiovascular diseases and total mortality. Journal of Hypertension. 35(4). 677–688. 128 indexed citations

Chen, Ying, Yuli Huang, & Weiyi Mai. (2015). Prehypertension or masked hypertension—which is responsible for target-organ damage?. Nature Reviews Cardiology. 12(8). 497–497. 5 indexed citations

10.

Cai, Xiaoyan, Yingying Li, Liang Su, et al.. (2014). Prehypertension and the risk of stroke. Neurology. 82(13). 1153–1161. 86 indexed citations

11.

Zheng, Dongdan, Anping Cai, Ling Liu, et al.. (2014). Baseline elevated Lp-PLA2 is associated with increased risk for re-stenosis after stent placement. Lipids in Health and Disease. 13(1). 41–41. 14 indexed citations

12.

Su, Liang, Xiaoyan Cai, Weiyi Mai, et al.. (2013). Association of all-cause and cardiovascular mortality with prehypertension: A meta-analysis. American Heart Journal. 167(2). 160–168.e1. 109 indexed citations

13.

Mai, Weiyi. (2012). Effect of zolpidem on blood pressure and blood pressure patterns in patients with hypertension complicated with insomnia. 1 indexed citations

14.

Qiu, Ruofeng, Anping Cai, Yugang Dong, et al.. (2012). SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects. Journal of Biomedical Science. 19(1). 99–99. 21 indexed citations

15.

Huang, Yuli, Ruofeng Qiu, Weiyi Mai, et al.. (2012). Effects of insulin-like growth factor-1 on the properties of mesenchymal stem cells in vitro. Journal of Zhejiang University SCIENCE B. 13(1). 20–28. 46 indexed citations

16.

Huang, Yuli, et al.. (2012). Bone marrow stromal cell transplantation combined with angiotensin-converting enzyme inhibitor treatment in rat with acute myocardial infarction and the role of insulin-like growth factor-1. Cytotherapy. 14(5). 563–569. 12 indexed citations

17.

Huang, Huiling, et al.. (2008). The oxidation ratio of LDL: A Predictor for Coronary Artery Disease. Disease Markers. 24(6). 341–349. 54 indexed citations

18.

Wang, Lichun, Hong Ma, Jiangui He, et al.. (2005). Effect of angiotensin converting enzyme inhibitor on the calcium transients and calcium handling proteins in ventricular myocytes from rats with heart failure.. PubMed. 118(9). 731–7. 3 indexed citations

19.

Mai, Weiyi, Dong Chen, Tianbing Ding, et al.. (2005). Inhibition ofPkhd1Impairs Tubulomorphogenesis of Cultured IMCD Cells. Molecular Biology of the Cell. 16(9). 4398–4409. 59 indexed citations

20.

Huang, Bingsheng, Yugang Dong, Weiyi Mai, & Yongqiang Li. (2005). Effect ofChlamydia pneumoniaeinfection and hyperlipidaemia on the expression of PPARγ, P50 and c-Fos in aortic endothelial cells in C57BL/6J mice. Acta Cardiologica. 60(1). 43–49. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact